Kwality Pharmaceuticals Complete Financial Statements
KPL • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Kwality Pharmaceuticals (KPL).
Downloads include all available records across all periods.
For market performance, see the
KPL stock price today
.
Profitability Ratios
Net Profit Margin
12.50%
2025 data
EBITDA Margin
23.21%
2025 data
Operating Margin
23.00%
2025 data
Return on Assets
3.13%
2025 data
Return on Equity
5.34%
2025 data
Balance Sheet Ratios
Current Ratio
18.93
2025 data
Debt to Equity
1.71
2025 data
Equity Ratio
58.61%
2025 data
Asset Turnover
0.25
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+24.4%
Year-over-Year
Net Profit Growth
+55.6%
Year-over-Year
EBITDA Growth
+30.0%
Year-over-Year
Expense Growth
+22.9%
Year-over-Year
Assets Growth
+13.5%
Year-over-Year
Equity Growth
+17.5%
Year-over-Year
Liabilities Growth
+13.5%
Year-over-Year
Operating Cash Flow Growth
+23.3%
Year-over-Year
Investing Cash Flow Growth
-11.5%
Year-over-Year
Financing Cash Flow Growth
+17.6%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Jun 2021 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 112 | 117 | 112 | 90 | 93 | 80 | 85 | 70 | 70 | 68 | 79 | 57 | 66 | 71 | 57 | 184 | 121 | 89 |
| Expenses | 86 | 90 | 87 | 70 | 78 | 63 | 67 | 54 | 74 | 54 | 61 | 40 | 48 | 52 | 41 | 100 | 73 | 64 |
| EBITDA | 26 | 27 | 25 | 20 | 14 | 18 | 18 | 16 | -4 | 14 | 17 | 17 | 18 | 18 | 16 | 84 | 49 | 25 |
| Operating Profit Margin % | 23.00% | 22.00% | 22.00% | 22.00% | 15.00% | 22.00% | 21.00% | 22.00% | -7.00% | 20.00% | 21.00% | 28.00% | 25.00% | 26.00% | 27.00% | 45.00% | 40.00% | 28.00% |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 4 | 5 | 5 | 4 | 3 | 3 | 4 | 3 | 2 | 3 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 19 | 19 | 17 | 13 | 6 | 11 | 11 | 8 | -10 | 7 | 10 | 12 | 14 | 14 | 10 | 80 | 46 | 22 |
| Tax | 4 | 5 | 5 | 4 | 2 | 3 | 3 | 2 | -2 | 2 | 2 | 2 | 4 | 4 | 3 | 21 | 11 | 6 |
| Net Profit | 14 | 15 | 12 | 9 | 4 | 8 | 9 | 6 | -7 | 5 | 8 | 9 | 11 | 11 | 7 | 60 | 34 | 16 |
| Earnings Per Share (₹) | 13.60 | 13.95 | 11.49 | 8.15 | 4.08 | 8.04 | 8.21 | 5.99 | -7.23 | 5.10 | 7.39 | 8.82 | 9.97 | 9.99 | 6.82 | 57.33 | 32.96 | 15.20 |
Related Pages for Kwality Pharmaceuticals
Additional stock information and data for KPL
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 447 | 394 | 354 | 341 | 166 | 133 | 105 | 96 | 71 | 51 | 37 |
| Current Assets | 284 | 243 | 207 | 228 | 106 | 89 | 75 | 75 | 53 | 38 | 25 |
| Fixed Assets | 146 | 139 | 121 | 92 | 57 | 43 | 29 | 20 | 17 | 13 | 13 |
| Capital Work in Progress | 0 | 0 | 14 | 12 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 4 | 3 | 4 | 5 | 3 | 2 | 1 |
| Other Assets | 302 | 255 | 219 | 237 | 102 | 87 | 72 | 71 | 51 | 37 | 24 |
| LIABILITIES | |||||||||||
| Total Liabilities | 447 | 394 | 354 | 341 | 166 | 133 | 105 | 96 | 71 | 51 | 37 |
| Current Liabilities | 15 | 20 | 29 | 21 | 28 | 20 | 8 | 6 | 4 | 3 | 1 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 262 | 223 | 199 | 180 | 60 | 45 | 36 | 29 | 25 | 21 | 19 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 5 | 5 | 4 |
| Reserves & Surplus | 254 | 214 | 190 | 171 | 51 | 36 | 27 | 19 | 20 | 17 | 15 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 53 | 43 | 41 | 61 | 27 | 6 | 14 | -1 | 4 | -3 | 1 |
| Investing Activities | -29 | -26 | -48 | -63 | -23 | -18 | -12 | -6 | -7 | -3 | -1 |
| Financing Activities | -14 | -17 | 1 | 6 | 1 | 12 | -2 | 5 | 5 | 6 | 1 |
| Net Cash Flow | 10 | -1 | -6 | 3 | 4 | 0 | 0 | -1 | 2 | 0 | 1 |